Richard D. Francis, President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 23,393 shares at $32.46 ($759K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $759k TEVA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2026-03-05 | $28.7M | — | Filing → |
| TEVA | SELL | 2026-02-18 | $30.6M | — | Filing → |
| TEVA | SELL | 2025-03-06 | $751K | — | Filing → |